A Clinical Trial to Demonstrate the Efficacy of Cangrelor

Clinical trial NCT00305162 · TERMINATED

Trial details

NCT number: NCT00305162
Sponsor: The Medicines Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Myocardial Infarction (MI)Acute Coronary Syndromes (ACS)

Start date: 2006-04-01
Primary completion: 2009-05-01
Enrollment: 8882

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.